LIG Biowise present the state of antimicrobial resistance at BioInfect 2017

This week, we had the privilege of attending and contributing to Bionow's BioInfect 2017 conference - a one day event looking at the critical issues relating to the development of new anti-infectives..

LIG Biowise
January 25, 2018

This week, we had the privilege of attending and contributing to Bionow's BioInfect 2017 conference - a one day event looking at the critical issues relating to the development of new anti-infectives and the endemic problem of resistance. Anti-microbial resistance is slowly gaining main-stream recognition as a non-trivial threat that needs to be addressed across multiple level of the healthcare system. 


We joined over 12 companies who presented the myriad problems within the anti-infective and microbial space. Our oresentation focused on the imperative of bringing new diagnostic techniques to market. As the majority of unnecessary antibiotics are prescribed at the point of care, predominantly in GP surgeries, it is on this line that we can fight to reduce the impact of antibiotic saturation on local populations. By reducing the number of unnecessary prescriptions the level of antimicrobial resistance within a population group falls; a local impact than can have cumulative ramifications on a much larger scale. 


You can visit the BioNow website here for more information